Potential molecular targets for translational stroke research.
作者信息
Vosler Peter S, Chen Jun
机构信息
Department of Neurology, S-507, BST, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
出版信息
Stroke. 2009 Mar;40(3 Suppl):S119-20. doi: 10.1161/STROKEAHA.108.533109. Epub 2008 Dec 8.
Abstract
摘要
相似文献
1
Potential molecular targets for translational stroke research.转化性中风研究的潜在分子靶点。
Stroke. 2009 Mar;40(3 Suppl):S119-20. doi: 10.1161/STROKEAHA.108.533109. Epub 2008 Dec 8.
2
5-HT1A receptor-mediated apoptosis: death by JNK?5-羟色胺1A受体介导的细胞凋亡：是由应激活化蛋白激酶导致的死亡吗？
Biochim Biophys Acta. 2007 Jun;1773(6):691-3. doi: 10.1016/j.bbamcr.2007.01.003. Epub 2007 Jan 10.
3
PPAR-gamma: therapeutic target for ischemic stroke.过氧化物酶体增殖物激活受体γ：缺血性中风的治疗靶点
Trends Pharmacol Sci. 2007 May;28(5):244-9. doi: 10.1016/j.tips.2007.03.004. Epub 2007 Apr 9.
4
Fashioning drugs for stroke.研发治疗中风的药物。
Nat Med. 2010 Dec;16(12):1376-8. doi: 10.1038/nm1210-1376.
5
Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.罗格列酮（一种过氧化物酶体增殖物激活受体γ配体）与NMDA受体拮抗剂（MK-801）联合治疗对大鼠实验性栓塞性中风的影响。
Basic Clin Pharmacol Toxicol. 2007 Nov;101(5):309-14. doi: 10.1111/j.1742-7843.2007.00127.x.
6
Response to open peer commentaries on "Bioethical considerations in translational research: primate stroke".对关于“转化研究中的生物伦理考量：灵长类动物中风”的公开同行评论的回应。
Am J Bioeth. 2009 May;9(5):W1-3. doi: 10.1080/15265160902851054.
7
Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.帕金森病小鼠模型中黑质致密部凋亡信号调节激酶1（ASK1）的激活及死亡相关蛋白Daxx的易位：α-硫辛酸的保护作用
FASEB J. 2007 Jul;21(9):2226-36. doi: 10.1096/fj.06-7580com. Epub 2007 Mar 16.
8
Animal models of stroke: do they have value for discovering neuroprotective agents?中风的动物模型：它们对发现神经保护剂有价值吗？
Trends Pharmacol Sci. 2003 Aug;24(8):402-8. doi: 10.1016/S0165-6147(03)00192-5.
9
Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke.罗昔洛韦抑制细胞周期依赖性激酶：急性缺血性脑卒中的神经保护作用。
Clin Pharmacol Ther. 2012 Feb;91(2):327-32. doi: 10.1038/clpt.2011.312. Epub 2012 Jan 4.
10
Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress.（-）-表没食子儿茶素-3-没食子酸酯在大鼠中风模型中的神经保护作用是通过抑制内质网应激介导的。
Mol Med Rep. 2014 Jan;9(1):69-76. doi: 10.3892/mmr.2013.1778. Epub 2013 Nov 6.
引用本文的文献
1
A Genome-Wide Analysis of the Penumbral Volume in Inbred Mice following Middle Cerebral Artery Occlusion.脑缺血后近交系小鼠半影区容积的全基因组分析
Sci Rep. 2019 Mar 25;9(1):5070. doi: 10.1038/s41598-019-41592-5.
2
Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy.趋化素通过 ChemR23/CAMKK2/AMPK 通路逆转新生鼠缺氧缺血性脑病的神经损伤并减轻神经元凋亡。
Cell Death Dis. 2019 Feb 4;10(2):97. doi: 10.1038/s41419-019-1374-y.
3
Platelets induce apoptosis via membrane-bound FasL.血小板通过膜结合型FasL诱导细胞凋亡。
Blood. 2015 Sep 17;126(12):1483-93. doi: 10.1182/blood-2013-12-544445. Epub 2015 Jul 31.
4
Uncoupling Neogenin association with lipid rafts promotes neuronal survival and functional recovery after stroke.解除新生蛋白与脂筏的关联可促进中风后神经元存活和功能恢复。
Cell Death Dis. 2015 May 7;6(5):e1744. doi: 10.1038/cddis.2015.109.
5
A critical role for interferon regulatory factor 9 in cerebral ischemic stroke.干扰素调节因子 9 在脑缺血性中风中的关键作用。
J Neurosci. 2014 Sep 3;34(36):11897-912. doi: 10.1523/JNEUROSCI.1545-14.2014.
6
First-order mathematical modeling of brain swelling in focal cerebral ischemia.局部脑缺血后脑水肿的一阶数学建模。
Transl Stroke Res. 2010 Mar;1(1):65-70. doi: 10.1007/s12975-009-0009-5. Epub 2010 Jan 20.
7
TRAF1 is a critical regulator of cerebral ischaemia-reperfusion injury and neuronal death.TRAF1 是脑缺血再灌注损伤和神经元死亡的关键调节因子。
Nat Commun. 2013;4:2852. doi: 10.1038/ncomms3852.
8
20-Hydroxyecdysone protects against oxidative stress-induced neuronal injury by scavenging free radicals and modulating NF-κB and JNK pathways.20-羟基蜕皮酮通过清除自由基和调节 NF-κB 和 JNK 通路来防止氧化应激诱导的神经元损伤。
PLoS One. 2012;7(12):e50764. doi: 10.1371/journal.pone.0050764. Epub 2012 Dec 11.
9
Do stroke models model stroke?中风模型能否模拟中风？
Dis Model Mech. 2012 Nov;5(6):718-25. doi: 10.1242/dmm.010033.
10
Delayed inhibition of c-Jun N-terminal kinase worsens outcomes after focal cerebral ischemia.c-Jun N-末端激酶的延迟抑制会加重局灶性脑缺血后的预后。
J Neurosci. 2012 Jun 13;32(24):8112-5. doi: 10.1523/JNEUROSCI.0219-12.2012.
本文引用的文献
1
A new penumbra: transitioning from injury into repair after stroke.一个新的半暗带：卒中后从损伤向修复的转变
Nat Med. 2008 May;14(5):497-500. doi: 10.1038/nm1735.
2
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.吡格列酮与2型糖尿病患者心血管事件风险：一项随机试验的荟萃分析
JAMA. 2007 Sep 12;298(10):1180-8. doi: 10.1001/jama.298.10.1180.
3
Neuroprotection and stroke: time for a compromise.神经保护与中风：是时候做出妥协了。
J Neurochem. 2007 Nov;103(4):1302-9. doi: 10.1111/j.1471-4159.2007.04866.x. Epub 2007 Aug 28.
4
The response of the aged brain to stroke: too much, too soon?老年大脑对中风的反应：过度且过早？
Curr Neurovasc Res. 2007 Aug;4(3):216-27. doi: 10.2174/156720207781387213.
5
PPAR-gamma: therapeutic target for ischemic stroke.过氧化物酶体增殖物激活受体γ：缺血性中风的治疗靶点
Trends Pharmacol Sci. 2007 May;28(5):244-9. doi: 10.1016/j.tips.2007.03.004. Epub 2007 Apr 9.
6
Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.靶向JNK丝裂原活化蛋白激酶级联反应进行抑制：基础科学与治疗潜力
Biochim Biophys Acta. 2004 Mar 11;1697(1-2):89-101. doi: 10.1016/j.bbapap.2003.11.016.
7
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia.一种c-Jun氨基末端激酶的肽类抑制剂可预防兴奋性毒性和脑缺血。
Nat Med. 2003 Sep;9(9):1180-6. doi: 10.1038/nm911. Epub 2003 Aug 24.
8
Pathobiology of ischaemic stroke: an integrated view.缺血性中风的病理生物学：综合观点。
Trends Neurosci. 1999 Sep;22(9):391-7. doi: 10.1016/s0166-2236(99)01401-0.
Zotero 插件